EnsiliTech
Company

EnsiliTech

Biotechnology Research Bristol, City of, United Kingdom 14 employees
Employees
14
Contacts
2
Emails
1
Phones
1

EnsiliTech Overview

Headquarters
Bristol, City of, United Kingdom
Industry
Biotechnology Research
Employees
14
Founded
2022
Funding
1.1M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About EnsiliTech

Our novel ensilication technology exploits the growth of protective silica nanoshells on the surface of vaccine components, to prevent degradation, which can lead to vaccine spoilage. Once applied, our vaccines can be stored and transported without the need for cold chain infrastructure, preventing wastage, improving shelf-life and increasing vaccine accessibility globally. Ensilication can be applied to protect a wide variety of biomolecules against environmental degradation, eliminating the need for cold chain requirements and propelling the development of more oral and mucosal delivery of vaccines and therapeutics for both animals and humans. We are actively looking for partners to work with us in developing new technologies free from the reliance on the cold chain. Please don't hesitate to contact us if you're interested in finding out more about us and the problem of cold chain dependent vaccines.

EnsiliTech Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
1
25.0% coverage
Phone contacts
1
25.0% coverage

EnsiliTech Org Chart

Sample employees and titles
Name Title Contact
Sabine Ficek Fractional CFO, Investor: #venturecapital (#deeptech #energy #climatetech)
View
Sarah Pollitt I Work as Chair of Ensilitech, a Bio-tech with an Innovative Thermal Stabilisation Technology for Vaccines and Mabs. I Am Also a Transformation
Email
Aswin Doekhie CTO & Co-founder at Ensilitech
View
Rachel Smith Laboratory Technician
Phone

Employees by Management Level

Executive 2 profiles
Individual contributor 2 profiles

Compare Similar Companies to EnsiliTech